Literature DB >> 21149249

Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey.

Marielle Bassel1, Marie Hudson, Suzanne S Taillefer, Orit Schieir, Murray Baron, Brett D Thombs.   

Abstract

OBJECTIVE: Knowledge about the range of symptoms experienced by patients with SSc, and their impact on daily functioning is limited. The objective of the present study was to identify symptoms of SSc that patients rated as frequent and that highly impacted their ability to carry out daily activities.
METHODS: A total of 464 persons with SSc responded to the Canadian Scleroderma Patient Survey of Health Concerns and Research Priorities, including questions regarding the frequency and impact of 69 SSc symptoms. Descriptive analyses were performed dichotomizing symptom frequencies as never or rarely vs sometimes, most of the time or always and symptom impact on daily activities as no or minimal impact vs moderate to severe impact.
RESULTS: The five highest rated symptoms in terms of frequency and moderate to severe impact on daily activities, respectively, were: fatigue (89 and 72%), RP (86 and 67%), hand stiffness (81 and 59%), joint pain (81 and 64%) and difficulty sleeping (76 and 59%). In addition to these symptoms, items related to decreased hand function (difficulty making a fist and difficulty holding objects) and pain (muscle pain and joint tenderness) were frequently endorsed and commonly associated with moderate to severe impact on daily activities.
CONCLUSION: This study confirmed the importance for quality of life of core symptoms of SSc, such as pain, fatigue and limitations in hand function. It also identified areas with very little research, such as sleep problems, that appear to play important roles in daily functioning, and that merit more focused study.

Entities:  

Mesh:

Year:  2010        PMID: 21149249     DOI: 10.1093/rheumatology/keq310

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  65 in total

1.  Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.

Authors:  Beth Wallace; Suzanne Kafaja; Daniel E Furst; Veronica J Berrocal; Peter A Merkel; James R Seibold; Maureen D Mayes; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2015-02-09       Impact factor: 7.580

2.  Evaluation of a mail-delivered, print-format, self-management program for persons with systemic sclerosis.

Authors:  Janet L Poole; Betty Skipper; Cindy Mendelson
Journal:  Clin Rheumatol       Date:  2013-05-09       Impact factor: 2.980

Review 3.  Clinical Trial Design Issues in Systemic Sclerosis: an Update.

Authors:  Jessica K Gordon; Robyn T Domsic
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

4.  New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Authors:  Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

5.  Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Authors:  Linda Kwakkenbos; Brett D Thombs; Dinesh Khanna; Marie-Eve Carrier; Murray Baron; Daniel E Furst; Karen Gottesman; Frank van den Hoogen; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Warren R Nielson; Serge Poiraudeau; Robert Riggs; Maureen Sauvé; Fredrick Wigley; Marie Hudson; Susan J Bartlett
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

6.  Exercise-induced brachial artery blood flow and vascular function is impaired in systemic sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; Ryan S Garten; Jayson R Gifford; Russell S Richardson; D Walter Wray; Tracy M Frech; Anthony J Donato
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

7.  Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.

Authors:  John D Pauling; Tracy M Frech; Michael Hughes; Jessica K Gordon; Robyn T Domsic; Marina E Anderson; Francesca Ingegnoli; Neil J McHugh; Sindhu R Johnson; Marie Hudson; Francesco Boin; Voon H Ong; Marco Matucci-Cerinic; Nezam Altorok; Marina Scolnik; Mandana Nikpour; Ankoor Shah; Janet E Pope; Dinesh Khanna; Ariane L Herrick
Journal:  J Scleroderma Relat Disord       Date:  2018-05-24

8.  Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms.

Authors:  Stefan Schanz; Jörg Henes; Anja Ulmer; Ina Kötter; Gerhard Fierlbeck; C D Claussen; Marius Horger
Journal:  Eur Radiol       Date:  2012-07-29       Impact factor: 5.315

9.  The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Authors:  Brooke Levis; Linda Kwakkenbos; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Clin Rheumatol       Date:  2016-12-10       Impact factor: 2.980

10.  Raynaud's phenomenon.

Authors:  Ashraful Haque; Michael Hughes
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.